BioRestorative Therapies, Inc. (BRTX) Financial Statements (2023 and Earlier)

Company Profile

Business Address 40 MARCUS DRIVE
MELVILLE, NY 11747
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 809 - Miscellaneous Health And Allied Services, Not (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments21,0273,065211845232167
Cash and cash equivalents21,0273,065211845232167
Receivables517322938693
Prepaid expense43610535    
Other undisclosed current assets   34302429
Total current assets:21,4683,1876918152062289
Noncurrent Assets
Operating lease, right-of-use asset358474590
Property, plant and equipment382268175328509643
Intangible assets, net (including goodwill)5906647398148899641,039
Intangible assets, net (excluding goodwill)5906647398148899641,039
Other undisclosed noncurrent assets   22224646
Total noncurrent assets:9861,1601,3971,0111,2391,5181,728
TOTAL ASSETS:22,4534,3471,4661,1921,7591,5802,017
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1868865,5731,8944,3403,8594,596
Accounts payable511191,9541,8942,4552,2842,549
Accrued liabilities1357182,921 1,8861,5752,047
Interest and dividends payable 49698    
Debt118 7,1463,6263,4681,8591,010
Derivative instruments and hedges, liabilities  9161,095216  
Other liabilities     1277
Other undisclosed current liabilities60158852,641329  
Total current liabilities:3641,04513,7219,2558,3535,8455,612
Noncurrent Liabilities
Long-term debt and lease obligation4934,634522524194298302
Long-term debt, excluding current maturities1914,270 524194298302
Operating lease, liability302364522
Liabilities, other than long-term debt   3738811
Accounts payable and accrued liabilities   3738811
Other undisclosed noncurrent liabilities(302)(364)(522)1810430 
Total noncurrent liabilities:4934,634522579242735313
Total liabilities:8565,67914,2429,8338,5956,5805,925
Stockholders' equity
Stockholders' equity attributable to parent, including:21,597(1,331)(12,776)(8,641)(6,837)(5,000)(3,908)
Common stock0286812653
Treasury stock, value      (32)
Additional paid in capital155,72788,22565,78655,26944,56236,95529,444
Accumulated deficit(134,146)(89,843)(78,570)(63,922)(51,404)(41,960)(33,324)
Other undisclosed stockholders' equity attributable to parent15      
Total stockholders' equity:21,597(1,331)(12,776)(8,641)(6,837)(5,000)(3,908)
TOTAL LIABILITIES AND EQUITY:22,4534,3471,4661,1921,7591,5802,017

Income Statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues46771301118136629
Cost of revenue
(Cost of Goods and Services Sold)
     (0)(262)
Gross profit:46771301118136367
Operating expenses(26,354)(2,829)(8,562)(7,759)(8,455)(7,834)(7,538)
Operating loss:(26,308)(2,752)(8,432)(7,648)(8,374)(7,797)(7,170)
Nonoperating expense(17,995)(8,521)(6,216)(4,870)(1,070)(839)(753)
Debt instrument, convertible, beneficial conversion feature     23288
Interest and debt expense(16,180)658(1,895)(1,416)(208)(10)(36)
Other undisclosed income from continuing operations before equity method investments, income taxes    2081036
Loss from continuing operations before income taxes:(60,483)(10,615)(16,543)(13,934)(9,445)(8,636)(7,923)
Income tax expense (benefit)    (1,291)3,272(2,923)
Net loss:(60,483)(10,615)(16,543)(13,934)(10,736)(5,365)(10,846)
Other undisclosed net income (loss) attributable to parent16,180(658)1,8951,4161,291(3,272)2,923
Net loss available to common stockholders, diluted:(44,303)(11,273)(14,648)(12,518)(9,445)(8,636)(7,923)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(60,483)(10,615)(16,543)(13,934)(10,736)(5,365)(10,846)
Comprehensive loss, net of tax, attributable to parent:(60,483)(10,615)(16,543)(13,934)(10,736)(5,365)(10,846)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: